NLRP3 and hepatitis A virus infection: These results suggest that rhil-1RA has the ability to eliminate ROS, reduce NLRP3 inflammasome generation, prevent pyroptosis, and compete with IL-1β to lower the severity of ConA-induced hepatitis.